Drug intelligence / Profile preview

pipethanate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Rectal
01

Overview

Pipethanate is a small molecule antimuscarinic agent with pharmacological actions similar to atropine. It acts as an antagonist at muscarinic acetylcholine receptors, leading to smooth muscle relaxation and reduction of spasticity in the gastrointestinal and urinary tracts. Pipethanate is primarily indicated for the symptomatic treatment of visceral spasms, gastrointestinal disorders (including irritable bowel syndrome), overactive bladder, biliary tract spasm, and other conditions characterized by excessive smooth muscle contraction. It can be administered orally, intramuscularly, intravenously, or rectally[1][2][3][4][5][6]. The drug is generally well-tolerated but may cause typical anticholinergic side effects such as dry mouth and blurred vision[6].

Brand names
panpurol
Other names
pipethanate ethobromidepipethanate ethylbromide
02

Targets

mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on pipethanate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pipethanate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call